Solace Lifesciences, the makers of NuCalm® , is a neuroscience company developing comprehensive, all-natural, easy to use, predictable, and reliable technologies to quickly resolve stress and restore the mind and body. NuCalm® was originally developed by a neuroscientist to treat patients suffering with post-traumatic stress disorder, typically comorbid with substance abuse. For the past 19 years, NuCalm® was continually researched, tested, validated and perfected so users can consistently and reliably achieve the desired result—to stop stress without drugs. The most recent 4 years have focused on simplifying the product delivery system without sacrificing efficacy. While NuCalm® is born from neuroscience, physics, and biochemistry, it’s a delightful and deeply restorative and repairing reprieve from everyday stressors and worries. NuCalm® is just the beginning of the innovative and revolutionary neuroscience technology that is being developed by Solace Lifesciences. NuCalm® has the world’s first and only patent for “systems and methods for balancing and maintaining the health of the human autonomic nervous system”. (U.S. Patent Registration No.: 9,079,030; Issued July 14, 2015. NuCalm® is not intended to diagnose, treat, or prevent any disease.)
Looking for a particular Solace Lifesciences employee's phone or email?
The Solace Lifesciences annual revenue was $11.4 million in 2026.
Jim Poole is the President and Chief Executive Officer of Solace Lifesciences.
9 people are employed at Solace Lifesciences.
Solace Lifesciences is based in Wilmington, Delaware.
The NAICS codes for Solace Lifesciences are [621, 62, 62199, 6219].
The SIC codes for Solace Lifesciences are [80, 809].